THE PULSE OF LIFE

A series of express screening tests named “The Pulse of Life” confined to the World Hypertension Day were performed by SANTO in a various region.

On the occasion of the World Hypertension Day, which is traditionally celebrated on the second Saturday of May, SANTO performed a series of express screening tests named “The Pulse of Life” in various regions of the country. As part of the social project, those interested got the opportunity to measure their blood pressure, determine the cholesterol level and get a doctor's advice, where appropriate. This important event was aimed at raising public awareness of the ways of preventing, timely diagnosing and treating arterial hypertension and heart diseases.

Express screening involving doctors from outpatient clinics has been arranged in Atyrau, Aktobe, Karaganda, Uralsk, Shymkent, Saran, and Rudny.  In cases where the screening participants’ blood pressure deviated from the norm of 120/80 mm, those participants got a doctor's advice. In addition to the treatment recommendations, booklets with information on the causes and dangerous consequences of hypertension were distributed among people, in order to minimize the risks associated with this serious disease.

Elena Arysheva, Public Relations Director of SANTO commented: “Our Company’s project “The Pulse of Life” is aimed to bring to public notice the need of timely diagnose cardiovascular diseases among families and friends, and the need of regular treatment. More than a thousand patients are covered by the project currently, and I am sure that express screening helps people seriously consider their health and take appropriate steps if necessary”.

According to the WHO, more than every fifth adult in the world has high blood pressure, which is the cause of the over half of deaths from strokes and heart diseases.

According to statistics, this problem is particularly acute in Kazakhstan; 49.8% of adults suffer from hypertension. While only 25% are aware of cardiovascular risk factors. In addition, according to doctors, only 27% of hypertension sufferers regularly take antihypertensive drugs; while only 22% of them achieve the target values.

Meanwhile, there is proven direct correlation between the blood pressure and cardiovascular diseases, which often result in a lethal outcome. Hypertension risk factors include genetic predisposition, diabetes, obesity, kidney diseases, excessive consumption of table salt or alcohol, smoking, stress, sedentary lifestyle. Hypertension arises from the joint effect of the above factors. Absence of appropriate treatment and/or disregard of the raised blood pressure can result in an infarction, brain stroke or kidney disease. That is the reason the hypertension is called the “silent killer”.

The express screenings tests allowed us not just to identity potential hypertensive patients, but also inform them about the severity of the disease and the need for timely treatment, train them the skills of self-monitoring of blood pressure, provide free access to the measurement of blood pressure, and promote among the general public the idea of preventive measures, a healthy lifestyle and healthy nutrition.

------------------------------------------------------------------------------------------------------------------------------------------

ABOUT SANTO:                                                                    

SANTO Member of Polpharma Group is a trade mark of Chimpharm JSC (KASE: CHFM). The Company develops, manufactures and delivers affordable medicines of high quality to the markets of Kazakhstan and Central Asia. Production facilities allow the Company to produce 1 billion 283 million tablets, capsules and granules; 294 million ampoules with injectable solutions; 6 million packages and bottles with solutions for infusion; 40 million vials of antibiotic powders (cephalosporins); 13 million vials of antibiotic powders (penems/mycins); 4.5 million vials of liquid oral medicines. The Company is a leader in the pharmaceutical market of Kazakhstan with a portfolio including more than 200 generics in 12 therapeutic categories for the treatment of diseases in various fields of therapy. SANTO is a responsible employer for over 1000 individuals in Shymkent and in all regions of Kazakhstan. The Company increases exports of its products to Turkmenistan, Kyrgyzstan, Mongolia, Tajikistan, Russia and Ukraine.

Tatyana Filipchik, PR Manager

SANTO

Address: 17/1 Al-Farabi Ave., Nurly Tau Polyfunctional Center, 5B block, 19th floor, 050013, Almaty, Kazakhstan

Phone: +7 (727) 3121833

e-mail: tatyana.filipchik@santo.kz